Sarilumab Beneficial for Polymyalgia Rheumatica Patients
THURSDAY, Oct. 5, 2023 (HealthDay News) -- For patients with polymyalgia rheumatica with relapse during tapering of glucocorticoid therapy, treatment with sarilumab, the human monoclonal antibody that binds to the interleukin-6 receptor α, is efficacious for achieving sustained remission and reducing cumulative glucocorticoid dose, according to a study published in the Oct. 5 issue of the New England Journal of Medicine.
Robert F. Spiera, M.D., from Weill Cornell Medical College in New York City, and colleagues conducted a phase 3 trial in which patients were randomly assigned to receive 52 weeks of a twice-monthly subcutaneous injection of either sarilumab or placebo plus a 14-week prednisone taper (60 and 58 patients, respectively). The primary outcome was sustained remission at 52 weeks.
The researchers found that at week 52, sustained remission occurred in 28 and 10 percent of patients in the sarilumab and placebo groups, respectively. At 52 weeks, the median glucocorticoid dose was significantly lower in the sarilumab group versus placebo group (777 versus 2,044 mg, respectively). Neutropenia, arthralgia, and diarrhea were the most common adverse events with sarilumab versus placebo (15 versus 0 percent; 15 versus 5 percent; and 12 versus 2 percent, respectively). Compared with the placebo group, the sarilumab group reported more treatment-related discontinuations (12 versus 7 percent).
"These findings indicate a glucocorticoid-sparing and remission-maintenance effect of sarilumab," the authors write.
The study was funded by Sanofi and Regeneron Pharmaceuticals, which manufacture sarilumab.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Related Posts
Breathing Dirty Air Could Raise Your Odds for Rheumatoid Arthritis
WEDNESDAY, March 16, 2022 (HealthDay News) -- Long-term exposure to air...
AHA News: Examinando las opciones saludables de arroz
MARTES, 29 de marzo de 2022 (American Heart Association News) -- Lo crean o no,...
Signs of Early Alzheimer’s May Be Spotted in Brain Stem
THURSDAY, Sept. 23, 2021 (HealthDay News) -- Certain changes in a part of the...
AHA News: High Blood Pressure Diagnosis Leads to Discovery of Complex Heart Issues
TUESDAY, March 15, 2022 (American Heart Association News) -- Childhood friends...